Dual-specificity phosphatases as targets for antineoplastic agents

被引:124
作者
Lyon, MA
Ducruet, AP
Wipf, P
Lazo, JS
机构
[1] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Chevron Sci Ctr, Dept Chem, Pittsburgh, PA 15260 USA
关键词
D O I
10.1038/nrd963
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Dual-specificity protein phosphatases are a subclass of protein tyrosine phosphatases that are uniquely able to hydrolyse the phosphate ester bond on both a tyrosine and a threonine or serine residue on the same protein. Dual-specificity phosphatases have a central role in the complex regulation of signalling pathways that are involved in cell stress responses, proliferation and death. Although this enzyme family is increasingly the target of drug discovery efforts in pharmaceutical companies, a summary of the salient developments in the biology and medicinal chemistry of dual-specificity phosphatases has been lacking. We hope that this comprehensive overview will stimulate further progress in the development of small-molecule inhibitors that could form the basis for a new class of target-directed therapeutic agents.
引用
收藏
页码:961 / 976
页数:16
相关论文
共 126 条
[1]  
[Anonymous], BIOCHIMICA BIOPHYSIC
[2]   Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation [J].
Baldin, V ;
Cans, C ;
Knibiehler, M ;
Ducommun, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :32731-32734
[3]   CRYSTAL-STRUCTURE OF HUMAN PROTEIN-TYROSINE-PHOSPHATASE 1B [J].
BARFORD, D ;
FLINT, AJ ;
TONKS, NK .
SCIENCE, 1994, 263 (5152) :1397-1404
[4]   Generation of an UGI library of phosphate mimic-containing compounds and identification of novel dual specific phosphatase inhibitors [J].
Bergnes, G ;
Gilliam, CL ;
Boisclair, MD ;
Blanchard, JL ;
Blake, KV ;
Epstein, DM ;
Pal, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (19) :2849-2854
[5]   Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation [J].
Bernardi, R ;
Liebermann, DA ;
Hoffman, B .
ONCOGENE, 2000, 19 (20) :2447-2454
[6]   Dysidiolide and related γ-hydroxy butenolide compounds as inhibitors of the protein tyrosine phosphatase, Cdc25 [J].
Blanchard, JL ;
Epstein, DM ;
Boisclair, MD ;
Rudolph, J ;
Pal, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) :2537-2538
[7]   A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase [J].
Blasina, A ;
Van de Weyer, I ;
Laus, MC ;
Luyten, WHML ;
Parker, AE ;
McGowan, CH .
CURRENT BIOLOGY, 1999, 9 (01) :1-10
[8]   Total synthesis of (+)-dysidiolide [J].
Boukouvalas, J ;
Cheng, YX ;
Robichaud, J .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (02) :228-229
[9]  
Brohm D, 2002, ANGEW CHEM INT EDIT, V41, P307, DOI 10.1002/1521-3773(20020118)41:2<307::AID-ANIE307>3.0.CO
[10]  
2-1